Your browser doesn't support javascript.
loading
Development of a physiologically-based pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment.
Troutman, John A; Rick, David L; Stuard, Sharon B; Fisher, Jeffrey; Bartels, Michael J.
Afiliação
  • Troutman JA; Central Product Safety, The Procter & Gamble Company, Cincinnati, OH, USA. Electronic address: troutman.ja@pg.com.
  • Rick DL; Toxicology & Environmental Research & Consulting, The Dow Chemical Company, Midland, MI, USA. Electronic address: LRick@dow.com.
  • Stuard SB; Central Product Safety, The Procter & Gamble Company, Cincinnati, OH, USA. Electronic address: stuard.sb@pg.com.
  • Fisher J; National Center for Toxicological Research, Food & Drug Administration, Jefferson, AR, USA. Electronic address: jeffrey.fisher@fda.hhs.gov.
  • Bartels MJ; Toxicology & Environmental Research & Consulting, The Dow Chemical Company, Midland, MI, USA. Electronic address: MJBartels@dow.com.
Regul Toxicol Pharmacol ; 73(2): 530-43, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26188115

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Incerteza / Etilenoglicóis / Acetatos / Modelos Biológicos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Incerteza / Etilenoglicóis / Acetatos / Modelos Biológicos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2015 Tipo de documento: Article